2026-10-06 · Institute for Women's Health
Dr. Alma Golden on Transforming Global Health Strategy Beyond Politics
with Dr. Alma Golden, Global Health Consultant — Institute for Women's Health

In the latest episode of the Health Policy Podcast, host Bryan Hyde interviews Dr. Alma Golden, a global health consultant and former USAID official. They discuss the evolution of global health strategy under the Trump administration, focusing on the Geneva Consensus Declaration and the shift towards bilateral agreements that respect the sovereignty of nations. Dr. Golden emphasizes the importance of family in health outcomes and the need for integrated care without ideological strings attached to funding.
Beyond Politics: A New Era in Global Health Strategy
Dr. Alma Golden Discusses New Era in Global Health Strategy
In a recent episode of the Health Policy Podcast, Dr. Alma Golden, a global health consultant at the Institute for Women's Health and former Assistant Administrator for the Bureau for Global Health at USAID, discussed the evolving landscape of global health strategy. The conversation, hosted by Bryan Hyde, centered on the intersection of politics and practical health initiatives, particularly under the current America First approach.
Dr. Golden, a pediatrician with extensive experience in public health, emphasized the importance of addressing global health issues without political strings attached. She noted that while the United States has historically approached global health with compassion, there have been instances where funding was tied to mandates that did not align with the priorities of recipient countries.
"Some groups would offer to give money as long as you would provide abortions in the country," Dr. Golden explained, highlighting a common issue in international health funding. She stressed the need for a more respectful approach that recognizes the sovereignty of nations and their unique healthcare needs.
Focus Areas of Global Health Strategy
Dr. Golden identified several key areas of focus within the current global health strategy, particularly maternal and child health. She pointed to successful initiatives that promote training for midwives, prenatal care, and access to essential vaccines. However, she also noted that past funding practices often imposed conditions that were not culturally appropriate or welcomed by the countries receiving aid.
The shift towards bilateral agreements, as opposed to funding through non-governmental organizations (NGOs), represents a significant change in strategy. This approach allows countries to determine their healthcare priorities without external mandates. Dr. Golden remarked, "We're looking for localization of care, and respecting their priorities."
The Geneva Consensus Declaration
A pivotal aspect of this new strategy is the Geneva Consensus Declaration, which Dr. Golden helped develop during her tenure in the Trump administration. The declaration aims to empower countries to take responsibility for their health systems without ideological conditions attached to funding.
Initially signed by 34 countries, the declaration has since grown to include 41 nations. Dr. Golden noted that countries have expressed a desire for integrated healthcare systems that address multiple health issues simultaneously, rather than fragmented approaches that separate services.
"Countries were often offended by the way the U.S. gave money," she said, explaining that many nations felt undermined by the conditions placed on aid. The Geneva Consensus Declaration seeks to rectify this by promoting a partnership model that respects national sovereignty.
Successes and Future Outlook
Dr. Golden highlighted the successes of the Geneva Consensus Declaration, including annual gatherings that foster collaboration among participating countries. These events have seen increasing participation, indicating a growing commitment to the principles outlined in the declaration.
One notable achievement has been the development of a curriculum for sex education that aligns with culturally appropriate values. Additionally, the Institute for Women's Health has created a women's optimal health framework to support comprehensive healthcare for women and families.
Despite the progress made, Dr. Golden acknowledged the potential for political shifts to impact these initiatives. "The political winds can blow very, very strongly," she said. However, she remains optimistic that the partnerships formed through this strategy can lead to lasting improvements in global health.
Dr. Golden concluded by underscoring the importance of family in health outcomes. "The family is the first healthcare system," she stated, emphasizing that supportive family structures can significantly enhance maternal and child health.
As global health strategies continue to evolve, the focus on collaboration and respect for national priorities may pave the way for more effective and sustainable healthcare solutions worldwide.
Interview Q&A
Q&A: Beyond Politics: A New Era in Global Health Strategy
Health Policy Podcast: Q&A with Dr. Alma Golden
Q: Can you tell us a little about your background?
A: I am a pediatrician and public health expert. I served as the Senate-confirmed Assistant Administrator for the Bureau for Global Health at USAID during the Trump administration and was the Chief Operating Officer for the Institute for Women's Health. Personally, I am a grandmother with 16 grandchildren.
Q: How do you view the intersection of politics and global health strategy?
A: The U.S. has had mixed success in addressing global health issues. While there have been compassionate responses to health crises, there have also been instances where funding was tied to political agendas, which complicated efforts.
Q: What areas does the current global health strategy focus on?
A: The strategy emphasizes maternal and child health, including training midwives, providing prenatal care, and ensuring access to vaccines and nutrition. It aims to respect the priorities of the countries involved rather than imposing external mandates.
Q: How has the approach changed under the Trump administration?
A: The Trump administration shifted from funding through NGOs to bilateral agreements between the U.S. and other governments. This approach allows countries to prioritize their own health needs without external conditions attached to funding.
Q: What is the Geneva Consensus Declaration?
A: The Geneva Consensus Declaration emerged from discussions about how the U.S. provides health funding. It emphasizes that countries should manage their healthcare systems without external mandates, particularly regarding issues like abortion, which is not considered an international right.
Q: What successes have been observed since the Geneva Consensus Declaration?
A: The declaration has grown from 34 to 41 countries. Annual commemorations have fostered community among participating nations, and there is ongoing work to implement effective health education and frameworks.
Q: Why is it important that funding for health initiatives is not tied to ideological outcomes?
A: When funding is not tied to ideological mandates, countries can focus on their actual health needs, such as improving childbirth outcomes. Trustworthy, faith-based health systems often provide effective care without ideological strings attached.
Q: What role does the family play in health systems?
A: The family is the first healthcare system, providing nutrition, education, and support. A supportive father can significantly improve prenatal outcomes by ensuring that mothers receive proper care and resources.
Q: Will the current approach to global health endure beyond the Trump administration?
A: While political changes can impact strategies, the current approach fosters self-sufficiency in partner countries, which could lead to long-term improvements. However, there may be efforts to reverse some progress.
Q: How do you feel about the future of global health partnerships?
A: I am optimistic that these partnerships can create sustainable healthcare systems. While challenges remain, the dignity afforded to these countries through collaboration is likely to have lasting effects.
Q: What is the significance of treating countries as partners rather than projects?
A: Treating countries as partners respects their sovereignty and allows them to take ownership of their health systems. This approach fosters accountability and encourages countries to develop tailored solutions that meet their unique needs.
Q: Can you discuss the importance of integrated healthcare systems?
A: Integrated healthcare systems allow for comprehensive care, addressing multiple health issues simultaneously. This approach is more efficient and effective, particularly in countries where resources are limited.
Q: What are some challenges still faced in global health initiatives?
A: While there is progress, challenges include ensuring consistent funding, navigating political changes, and addressing humanitarian crises that require immediate response. Continuous adaptation and collaboration are essential.
Key takeaways
- “I think that we can totally understand why and how the American people got involved in some of the health issues.”
- “One of the big ones that kept coming up is that some groups would offer to give money as long as you would provide abortions in the country.”
- “What can the country develop that they know is their priority and develop systems of care that are in line with what they really need.”
- “The family is the first healthcare system.”
- “If you have a father in that environment that recognizes the value of his wife and his children, he helps ensure that she gets the right nutrition.”
About the guest

Global Health Consultant — Institute for Women's Health
Peter Pitts is President and co-founder of the Center for Medicine in the Public Interest. He also serves as a Visiting Professor at University of Paris School of Medicine. Pitts lives in New York City Professor Pitts is a former member of the United States Senior Executive Service and Associate Commissioner of the US Food & Drug Administration where he served as senior communications and policy adviser to the Commissioner. He supervised FDA's Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues, Office of Executive Secretariat, and Advisory Committee Oversight and Management. He served on the agency’s obesity working group and counterfeit drug taskforce. He is a member of the Council for International Organizations of Medical Sciences (CIOMS) Expert Working Group to help advance patient involvement in the development and safe use of medicines. (CIOMS is an international, non-governmental, non-profit organization established jointly by WHO and UNESCO in 1949.) He is the lead author of many professional peer reviewed publications including the Lancet, Therapeutic Innovation and Regulatory Science, and Nature Biotechnology. He is an Associate Editor of Therapeutic Innovation & Regulatory Science (the official DIA journal), a member of the External Advisory Board, IMS Institute for Healthcare Informatics in Asia, Executive Advisory Board, the Galien Foundation, Editorial Advisory Board, Food and Drug Policy Forum, Advisory Board, Journal of Commercial Biotechnology and a member of the Editorial Advisory Board of The Patient Magazine.
Full transcript
Show full transcriptHide transcript
Filed under
